Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
Deng, Ting, Zhang, Le, Liu, Xiao-jian, Xu, Jian-ming, Bai, Yu-xian, Wang, Yan, Han, Yu, Li, Yu-hong, Ba, YiТом:
30
Мова:
english
Журнал:
Medical Oncology
DOI:
10.1007/s12032-013-0752-z
Date:
December, 2013
Файл:
PDF, 199 KB
english, 2013
File converter
Більше результатів пошуку
More benefits 
